SCHEMBL5828868

SCHEMBL5828868

COc1cc2ncnc(N/C(=N\c3c(C)cccc3C)NCCN(C)C)c2cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.48
HPGD P15428 2/20 0.48
ALDH1A1 P00352 1/20 0.48
RET P07949 7/20 0.47
EGFR P00533 7/20 0.45
KIF5B P33176 6/20 0.45
KDR P35968 5/20 0.44
MAPK1 P28482 3/20 0.44
RAF1 P04049 1/20 0.44
FGFR1 P11362 1/20 0.44
FLT1 P17948 1/20 0.44
CDK2 P24941 1/20 0.44
PIK3R1 P27986 1/20 0.44
EPHB2 P29323 1/20 0.44
TTBK1 Q5TCY1 1/20 0.44
MEN1 O00255 1/20 0.44
STAT3 P40763 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NOD1 Q9Y239 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828872 1.00 HTT (0.48) HTTHPGDALDH1A1RETEGFR
SCHEMBL5827885 0.94 RET (0.47) HTTHPGDALDH1A1RETEGFR
SCHEMBL5827881 0.94 RET (0.47) HTTHPGDALDH1A1RETEGFR
SCHEMBL6981093 0.94 EGFR (0.47) HTTHPGDALDH1A1RETEGFR
SCHEMBL5828729 0.93 EGFR (0.50) HTTHPGDALDH1A1RETEGFR
SCHEMBL5828728 0.93 EGFR (0.50) HTTHPGDALDH1A1RETEGFR
SCHEMBL6986020 0.88 EGFR (0.46) HTTHPGDALDH1A1RETEGFR
SCHEMBL5828850 0.88 KDM1A (0.49) HTTHPGDALDH1A1RETEGFR
SCHEMBL5828851 0.88 KDM1A (0.49) HTTHPGDALDH1A1RETEGFR
SCHEMBL6981726 0.86 EPHA2 (0.57) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed